TGA Approval

WEZLANA ustekinumab 45 mg / 0.5 mL solution for subcutaneous injection vial (403012)

ARTG ID

403012

ARTG Name

WEZLANA ustekinumab 45 mg / 0.5 mL solution for subcutaneous injection vial

Sponsor

Amgen Australia Pty Ltd

ARTG Date

January 22, 2024

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Amgen Australia Pty Ltd.

Ingredient Name

Ustekinumab

Empowering clinical research with data-driven insights and AI-powered tools.

WEZLANA ustekinumab 45 mg / 0.5 mL solution for subcutaneous injection vial (403012) - TGA 批准文号 | MedPath